Effect of Weight Reduction Intervention versus Standard of Care among People Living with HIV Experiencing Significant Weight Gain from Dolutegravir-Based Regimens: RCT
Phase 3
Recruiting
- Conditions
- weight gain from DTGweight gainDTGweight reduction intervention
- Registration Number
- TCTR20240818003
- Lead Sponsor
- Faculty of Medicine, CHIANG MAI University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
1 age more than 20 years
2 weight gain more than 5% from baseline after receiving dolutegravir at least 6 months
3 can give inform consent
4 understand and use Thai language
5 TMSE more than 24 points
Exclusion Criteria
1 steroid use
2 on TAF
3 underlying schizophrenia
4 alcohol addiction
5 can not walk more than 400 meter
6 can not follow up
7 plan to migrate in research period
8 post gastrectomy for weight reduction
9 on any medication for weight loss
10 weight reduction by themselves more than 4.5 kg in 3 months or as baseline
11 BMI less than 18.5 kg/m2
12 weight more than 158 kg
13 on hormonal therapy
14 having any underlying disease that may obstruct trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method